Crucell and DSM Announce Licensing Agreement With Mitsubishi

Dutch biotechnology company Crucell N.V. and allied contract manufacturer DSM Biologics announced that DSM Biologics has signed a PER.C6 research license agreement with the Japanese pharmaceutical company Mitsubishi Pharma Corporation. This license agreement allows Mitsubishi to use the PER.C6 cell line for production of certain recombinant therapeutic proteins. This license agreement is the second license agreement signed by DSM Biologics with a Japanese company in the course of this month.

Yahoo News (http://biz.yahoo.com/pz/050323/74985.html)